Dan Mercola and John Welsh are at The Sidney Kimmel Cancer Center, San Diego, California, USA. danmercola@skcc.org
The combination of inhibition of RNA degradation and comparative genomic scanning is a powerful new method for detecting gene disruptions. The utility of the method is well-illustrated by a series of observations linking the ephrin receptor EPHB2 to prostate cancer.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
